Skip to main content
. 2022 Nov 8;89(3):1176–1186. doi: 10.1111/bcp.15569

TABLE 3.

Multivariable linear mixed effects regression analysis of the corrected QT interval in malaria following treatment with amodiaquine

QTcS—Study‐specific correction (ms) QTcF—Fridericia correction (ms) QTcB—Bazett correction (ms)
Univariable analyses Multivariable analyses Univariable analyses Multivariable analyses Univariable analyses Multivariable analyses
Number of observations Crude estimate (95% CI) P value Adjusted estimate (95% CI) P value Crude estimate (95% CI) P value Adjusted estimate (95% CI) P value Crude estimate (95% CI) P value Adjusted estimate (95% CI) P value
Total plasma concentration of amodiaquine and desethylamodiaquine, per 750 a nmol/L increase 356 12.98 (8.73–17.16) <.0001 10.43 (5.92–15.00) <.0001 20.35 (15.56–25.15) <.0001 10.67 (6.13–15.21) <.0001 6.10 (1.80–10.38) .0055 10.26 (5.71–14.81) <.0001
Body temperature change, per 1°C increase 356 −5.30 (−7.12 to −3.47) <.0001 −3.97 (−6.49 to −1.46) .0021 −10.59 (−12.52 to −8.65) <.0001 −4.04 (−6.57 to −1.52) .0018 −0.374 (−2.25 to 1.50) .6948 −3.90 (−6.43 to −1.37) .0026
Sex 356
Female 187 Reference Reference Reference Reference Reference Reference
Male 169 −16.24 (−25.48 to −7.00) .0009 −17.35 (−26.62 to −8.08) .0004 −12.72 (−22.11 to −3.34) .0088 −13.30 (−22.94 to −3.66) .0078 −19.54 (−29.00 to −10.08) .0001 −21.05 (−30.57 to −11.52) <.0001
Age, per 10‐year increase 356 2.33 (−0.25 to 0.71) .3339 4.16 (−0.17 to 8.49) .0595 2.87 (−1.78 to 7.52) .2209 4.47 (−0.30 to 8.98) .0515 1.78 (−3.32 to 6.88) .4859 3.87 (−0.57 to 8.32) .0864
RR interval change, per 300 b ms increase 356 7.50 (4.46–10.54) <.0001 −0.42 (−4.80 to 3.95) .8475 19.69 (16.65–22.74) <.0001 11.63 (7.25–16.01) <.0001 −3.69 (−6.75 to −0.65) .0177 −11.45 (−15.84 to −7.06) <.0001

QTcS=QTRR0.42&QTcF=QTRR3&QTcB=QTRR, where RR is in units of s.

a

Mean maximum total plasma drug concentration (rounded) after a 3‐day course of amodiaquine from pharmacokinetic analysis of same study.

b

Mean change in RR interval from baseline (rounded) after last dose of amodiaquine treatment in this study.

CI, confidence interval.